Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could interval training and fasting tame PCOS insulin resistance?

NCT ID NCT07708766

Not yet recruiting Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study investigates whether combining high-intensity interval training (HIIT) with intermittent fasting (14-hour fast, 10-hour eating window) can reduce insulin resistance in obese women with polycystic ovary syndrome (PCOS). Participants will follow a supervised exercise program and a 1400-calorie diet during eating hours. The researchers will measure changes in body weight, waist and hip circumference, blood sugar, and insulin levels, as well as quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
high-intensity interval training and intermittent fasting diet
What this could lead to
If effective, this combination could offer a drug-free way to manage insulin resistance and improve quality of life in women with PCOS.
What could go wrong
This is a small, early-stage study with 50 participants, so results may not apply to all women with PCOS. The diet and exercise regimen may be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POLYCYSTIC OVARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POLYCYSTIC OVARY SYNDROME

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hager Tharwat Mohamed

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.